Carregant...
Clinical and Molecular Phenotyping in Scleromyxedema Pre- and Post-Treatment with Intravenous Immunoglobulin
BACKGROUND: Scleromyxedema (SMX) is a rare systemic sclerosis mimic that often responds to intravenous immunoglobulin therapy (IVIG), yet the resulting clinical and biochemical changes have not been well characterized. METHODS: Fifteen patients with SMX were recruited for the study. Clinical informa...
Guardat en:
| Publicat a: | Arthritis Care Res (Hoboken) |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6810715/ https://ncbi.nlm.nih.gov/pubmed/31008568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.23908 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|